MedPath

Study to evaluate the effect of chondroitin sulfate on the synovitis in patients with knee osteoarthritis

Completed
Conditions
Osteoarthritis
Musculoskeletal Diseases
Registration Number
ISRCTN64282813
Lead Sponsor
Hospital del Mar (Spain)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
70
Inclusion Criteria

1. Men or women 40 years or older
2. Fulfilment of the American College of Rheumatology (ACR) classification criteria for clinical KOA
3. Presence of radiographic OA in the knee joint, defined as a Kellgren and Lawrence (K&L) score of 2 or 3.
4. Ultrasonography presence of synovitis plus joint effusion thickness =4 mm

Exclusion Criteria

1. Any serious disease (such as decompensate heart disease, diabetes, fibromyalgia, renal insufficiency, liver disease or malignancies)
2. Secondary OA
3. Use of any medication already know to affect the variables examined (oral corticosteroids, intra-articular corticosteroids, or any SYSADOA within 3 previous months before study enrolment, or any nonsteroidal anti-inflammatory drug within 30 days before study?s enrolment)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath